Cardica, Inc. (NASDAQ:CRDC)

CAPS Rating: 3 out of 5

The Company designs, manufactures and markets proprietary automated anastomotic systems used by surgeons to perform coronary artery bypass surgery.

Results 1 - 19 of 19

Recs

0
Member Avatar maphere (< 20) Submitted: 3/7/2012 4:22:47 PM : Outperform Start Price: $1.93 CRDC Score: -88.15

New stapler design superior to existing surgical staplers, likely to complete clinical trial 4th Quarter. Expect buyout by EOY.

Recs

0
Member Avatar Cressida (64.27) Submitted: 1/23/2011 2:44:27 PM : Outperform Start Price: $5.15 CRDC Score: -134.71

Surgical needs increasing in this arena (see World Stats Review).
Cardica is now rev-ing up it's contract with ISRG, which may result in buyout. It is down and costing plenty to assure delivery of product to ISRG. Need is increasing, eg, demand will increase.
Even small town hospitals (Chambersburg, PA) now do robotic surgery....and advertise that !!!!

Recs

0
Member Avatar Mathias (78.19) Submitted: 9/10/2008 1:28:10 PM : Outperform Start Price: $9.88 CRDC Score: -156.09

This is a re-up. PAS-Port approval starts a new phase of growth for this company.

Recs

0
Member Avatar MagicTX (45.31) Submitted: 9/9/2008 6:00:40 PM : Outperform Start Price: $10.20 CRDC Score: -156.21

FDA approval will send this stock upward.

Recs

0
Member Avatar davidr825 (< 20) Submitted: 6/13/2008 7:58:39 PM : Outperform Start Price: $9.17 CRDC Score: -140.49

Robotic surgery will be the wave of the future

Recs

0
Member Avatar GamblerRoy22 (< 20) Submitted: 6/12/2008 6:29:38 PM : Outperform Start Price: $9.86 CRDC Score: -143.39

with its new development in heart surgery this company should be able to erase its debt with little to no effort.

Recs

0
Member Avatar amytobin (< 20) Submitted: 6/10/2008 5:23:37 PM : Outperform Start Price: $9.71 CRDC Score: -141.00

Demand for medical supplies always needed

Recs

0
Member Avatar rdevine1955 (32.05) Submitted: 6/10/2008 2:31:24 PM : Outperform Start Price: $9.15 CRDC Score: -140.24

promotional merchandise advertises cardica
to Medical Professionals who make the decisions.
Trend analysis says this is going up

Recs

3
Member Avatar TMFBreakerJava (99.52) Submitted: 5/10/2008 6:22:27 AM : Outperform Start Price: $7.09 CRDC Score: -133.68

This company has a device that facilitates minimally invasive coronary bypass surgery in conjunction with the Da Vinci robotic surgical system from ISRG. Coronary bypass surgery is a large market in need of a less traumatic solution than the prevailing standard of care, which involves splitting the chest, stopping the heart and weeks of painful recovery.

This company's product facilitates the minimally invasive solution provided by the da Vinci robot which allows closed chest, beating heart bypass surgery with far faster recovery and much less post surgical pain.

Perhaps ISRG will acquire them, but this is a promising investment with or without the acquisition

Recs

0
Member Avatar gator511 (< 20) Submitted: 3/27/2008 2:07:56 PM : Outperform Start Price: $7.77 CRDC Score: -142.05

New devices coming on line later this year and the company may actually start turning a profit by 1st quarter next year

Recs

0
Member Avatar betabata (< 20) Submitted: 3/5/2008 3:23:33 PM : Outperform Start Price: $7.83 CRDC Score: -142.80

breakthrough device

Recs

0
Member Avatar gparent2008 (24.08) Submitted: 12/14/2007 4:32:36 PM : Underperform Start Price: $10.90 CRDC Score: +130.98

had a nice bounce now bak 2 reality

Recs

0
Member Avatar cysto (92.90) Submitted: 11/9/2007 2:06:19 PM : Underperform Start Price: $8.47 CRDC Score: +130.36

CABG surgery is on the decline and largely replaced by stenting. I don't see this being a real winner in the long run unless it is bought out

Recs

0
Member Avatar P01 (45.47) Submitted: 10/26/2007 1:34:00 AM : Outperform Start Price: $13.50 CRDC Score: -129.09

I am sure

Recs

0
Member Avatar sal1015 (< 20) Submitted: 10/17/2007 9:15:45 AM : Outperform Start Price: $11.65 CRDC Score: -126.07

Their non-invasive procedure has been proven effective and is sure to be accepted by the medical community. The potential for the company is considerably higher than the market cap and eventually will trade at levels that closely resemble that potential. Although I agree that the recent dilution will put some short term pressure on the stock, the company is using its current sucess as a means of raising money that is essential to their growth and allowing their angel investor an opportunity to cash out. NONE of the key players in the company is selling stock here.

Recs

0
Member Avatar tling (62.57) Submitted: 10/10/2007 4:51:36 PM : Outperform Start Price: $13.84 CRDC Score: -125.91

The science sounds promising. I can't wait until I get my first bypass!

Recs

0
Member Avatar anylawn (< 20) Submitted: 10/7/2007 12:11:45 PM : Outperform Start Price: $12.83 CRDC Score: -126.60

Found this stock on the new marketwatch community website.

Recs

0
Member Avatar razormd (73.67) Submitted: 9/13/2007 3:56:28 PM : Outperform Start Price: $9.38 CRDC Score: -130.14

Reviewed the technology and found it very impressive...c-port is now cleared for use in the US and the European union...Dr. Katz, one of the surgeons who recently used the device, said:

"The Flex A system has the potential to revolutionize the field of cardiothoracic surgery, as it enhances closed-chest, robot-assisted bypass procedures. Minimally-invasive bypass surgeries produce better patient outcomes, and substantially reduce pain and trauma and provide a quicker return to normal functionality for the patient."

...now take a look at a chart of ISRG...need I say more?

Recs

0
Member Avatar SteadySaber (71.34) Submitted: 9/6/2007 11:37:24 AM : Underperform Start Price: $10.08 CRDC Score: +131.56

Conducting DD on this but right now it goes down. Sell the news.

Results 1 - 19 of 19

Featured Broker Partners


Advertisement